Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pregabalin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pregabalin 82.5mg modified-release tablets
0408010AEAABDBD
|
Pregabalin | Pregabalin | Central Nervous System | 1 |
|
Rewisca 150mg capsules
0408010AEBCAEAE
|
Rewisca | Pregabalin | Central Nervous System | 1 |
|
Lecaent 150mg capsules
0408010AEBDAEAE
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 200mg capsules
0408010AEBDAFAF
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 225mg capsules
0408010AEBDAGAI
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 25mg capsules
0408010AEBDAAAA
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 300mg capsules
0408010AEBDAHAG
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 75mg capsules
0408010AEBDACAC
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Misabri PR 165mg pro-longed release tablets
0408010AEBGAABB
|
Misabri | Pregabalin | Central Nervous System | No data available |
|
Misabri PR 330mg pro-longed release tablets
0408010AEBGABBC
|
Misabri | Pregabalin | Central Nervous System | No data available |
|
Misabri PR 82.5mg pro-longed release tablets
0408010AEBGACBD
|
Misabri | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 200mg/5ml oral liquid
0408010AEAAAKAK
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 25mg/5ml oral liquid
0408010AEAAAMAM
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 300mg/5ml oral suspension
0408010AEAAARAR
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 50mg/5ml oral suspension
0408010AEAAAQAQ
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 75mg oral powder sachets
0408010AEAAALAL
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Rewisca 100mg capsules
0408010AEBCAAAD
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 200mg capsules
0408010AEBCAFAF
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 225mg capsules
0408010AEBCAGAI
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 25mg capsules
0408010AEBCABAA
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 300mg capsules
0408010AEBCAHAG
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 50mg capsules
0408010AEBCACAB
|
Rewisca | Pregabalin | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.